Liu Y - Search Results

1

Preparation and Characterization of a Novel Monoclonal Antibody Against the Extracellular Domain of Human Transferrin Receptor.

Li X, Yang L, Yang Y, Shao M, Liu Y. Li X, et al. Among authors: liu y. Monoclon Antib Immunodiagn Immunother. 2017 Feb;36(1):1-7. doi: 10.1089/mab.2016.0025. Epub 2017 Feb 16. Monoclon Antib Immunodiagn Immunother. 2017. PMID: 28234558

2

A Novel Specific Anti-CD73 Antibody Inhibits Triple-Negative Breast Cancer Cell Motility by Regulating Autophagy.

Qiao Z, Li X, Kang N, Yang Y, Chen C, Wu T, Zhao M, Liu Y, Ji X. Qiao Z, et al. Among authors: liu y. Int J Mol Sci. 2019 Feb 28;20(5):1057. doi: 10.3390/ijms20051057. Int J Mol Sci. 2019. PMID: 30823477 Free PMC article.

3

Neutralization of TNFα in tumor with a novel nanobody potentiates paclitaxel-therapy and inhibits metastasis in breast cancer.

Ji X, Peng Z, Li X, Yan Z, Yang Y, Qiao Z, Liu Y. Ji X, et al. Among authors: liu y. Cancer Lett. 2017 Feb 1;386:24-34. doi: 10.1016/j.canlet.2016.10.031. Epub 2016 Nov 7. Cancer Lett. 2017. PMID: 27832973

4

A convenient method for hTfR1 inclusion body purification.

Shao M, Peng ZX, Shi CY, Tang R, Manzo LM, Liu Y. Shao M, et al. Among authors: liu y. Prep Biochem Biotechnol. 2015;45(8):743-53. doi: 10.1080/10826068.2014.952383. Prep Biochem Biotechnol. 2015. PMID: 25207990

5

CPU-12, a novel synthesized oxazolo[5,4-d]pyrimidine derivative, showed superior anti-angiogenic activity.

Liu J, Deng YH, Yang L, Chen Y, Lawali M, Sun LP, Liu Y. Liu J, et al. Among authors: liu y. J Pharmacol Sci. 2015 Sep;129(1):9-17. doi: 10.1016/j.jphs.2015.06.001. Epub 2015 Jun 20. J Pharmacol Sci. 2015. PMID: 26154846 Free article.

6

pH-Responsive de-PEGylated nanoparticles based on triphenylphosphine-quercetin self-assemblies for mitochondria-targeted cancer therapy.

Xing L, Lyu JY, Yang Y, Cui PF, Gu LQ, Qiao JB, He YJ, Zhang TQ, Sun M, Lu JJ, Xu X, Liu Y, Jiang HL. Xing L, et al. Among authors: liu y. Chem Commun (Camb). 2017 Aug 11;53(62):8790-8793. doi: 10.1039/c7cc04058j. Epub 2017 Jul 24. Chem Commun (Camb). 2017. PMID: 28736782

7

A novel anti-VEGF165 monoclonal antibody-conjugated liposomal nanocarrier system: physical characterization and cellular uptake evaluation in vitro and in vivo.

Shi C, Gao F, Gao X, Liu Y. Shi C, et al. Among authors: liu y. Biomed Pharmacother. 2015 Feb;69:191-200. doi: 10.1016/j.biopha.2014.11.025. Epub 2014 Nov 25. Biomed Pharmacother. 2015. PMID: 25661357

8

Expression of 5T4 extracellular domain fusion protein and preparation of anti-5T4 monoclonal antibody with high affinity and internalization efficiency.

Wang R, Lai Q, Lu Y, Zhou Y, Tang L, Tao Y, Yao Y, Yu L, Liu Y, Wang Y, Zhang R, Jiang X, Gou L, Yang J. Wang R, et al. Among authors: liu y. Protein Expr Purif. 2019 Jun;158:51-58. doi: 10.1016/j.pep.2018.07.003. Epub 2018 Jul 6. Protein Expr Purif. 2019. PMID: 29981846

9

Novel drug delivery liposomes targeted with a fully human anti-VEGF165 monoclonal antibody show superior antitumor efficacy in vivo.

Shi C, Cao H, He W, Gao F, Liu Y, Yin L. Shi C, et al. Among authors: liu y. Biomed Pharmacother. 2015 Jul;73:48-57. doi: 10.1016/j.biopha.2015.05.008. Epub 2015 May 30. Biomed Pharmacother. 2015. PMID: 26211582

10

Isolation and characterization of human anti-VEGF165 monoclonal antibody with anti-tumor efficacy from transgenic mice expressing human immunoglobulin loci.

Liu Y, Yun DJ, Chen JQ, Zhao JY, Liu SG, Cheng GX. Liu Y, et al. Among authors: liu sg. Cancer Lett. 2009 Jan 8;273(1):28-34. doi: 10.1016/j.canlet.2008.07.022. Epub 2008 Sep 6. Cancer Lett. 2009. PMID: 18774636

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208,324 results

Search Page

Filters